143 related articles for article (PubMed ID: 17620295)
1. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
[TBL] [Abstract][Full Text] [Related]
2. Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
Perotti D; Gamba B; Sardella M; Spreafico F; Terenziani M; Collini P; Pession A; Nantron M; Fossati-Bellani F; Radice P
Oncogene; 2008 Jul; 27(33):4625-32. PubMed ID: 18391980
[TBL] [Abstract][Full Text] [Related]
3. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
[TBL] [Abstract][Full Text] [Related]
4. Wilms tumor genetics: a new, UnX-pected twist to the story.
Huff V
Cancer Cell; 2007 Feb; 11(2):105-7. PubMed ID: 17292822
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
Liu Y; Liu S
Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
[TBL] [Abstract][Full Text] [Related]
6. Canonical WNT signalling determines lineage specificity in Wilms tumour.
Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
[TBL] [Abstract][Full Text] [Related]
7. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.
Rivera MN; Kim WJ; Wells J; Driscoll DR; Brannigan BW; Han M; Kim JC; Feinberg AP; Gerald WL; Vargas SO; Chin L; Iafrate AJ; Bell DW; Haber DA
Science; 2007 Feb; 315(5812):642-5. PubMed ID: 17204608
[TBL] [Abstract][Full Text] [Related]
8. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
[TBL] [Abstract][Full Text] [Related]
9. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
[TBL] [Abstract][Full Text] [Related]
10. Is WTX a suitable target for cancer therapy?
Perotti D; Radice P
Pediatr Blood Cancer; 2011 Apr; 56(4):682. PubMed ID: 21298763
[No Abstract] [Full Text] [Related]
11. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
12. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
13. The T-ALL specific t(11;14)(p13;q11) translocation breakpoint cluster region is located near to the Wilms' tumour predisposition locus.
Boehm T; Lavenir I; Forster A; Wadey RB; Cowell JK; Harbott J; Lampert F; Waters J; Sherrington P; Couillin P
Oncogene; 1988 Dec; 3(6):691-5. PubMed ID: 2577871
[TBL] [Abstract][Full Text] [Related]
14. Cancer. Converging on beta-catenin in Wilms tumor.
Nusse R
Science; 2007 May; 316(5827):988-9. PubMed ID: 17510350
[No Abstract] [Full Text] [Related]
15. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids.
Finver SN; Martiniere C; Kagan J; Cavenee W; Croce CM
Oncogene Res; 1989; 5(2):143-8. PubMed ID: 2558334
[TBL] [Abstract][Full Text] [Related]
16. New tumour suppressor linked to Wilms' tumour.
Bagchi S
Lancet Oncol; 2007 Feb; 8(2):102. PubMed ID: 17290504
[No Abstract] [Full Text] [Related]
17. Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants.
Kim MK; Min DJ; Rabin M; Licht JD
Oncogene; 2011 Feb; 30(7):832-42. PubMed ID: 20956941
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of a reciprocal translocation t(5;11) (q11;p13) in a WAGR patient.
Puissant H; Azoulay M; Serre JL; Piet LL; Junien C
Hum Genet; 1988 Jul; 79(3):280-2. PubMed ID: 2841227
[TBL] [Abstract][Full Text] [Related]
19. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]